Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Oncogenomics
  • Published:

Molecular analysis of transitional cell carcinoma using cDNA microarray

Abstract

The incidence of transitional cell carcinoma (TCC), the fourth most common neoplasm diagnosed in men, is rising. Despite the development of several noninvasive diagnostic tests, none have gained full recognition by the clinicians. Gene expression profiling of tumors can identify new molecular markers for early diagnosis and disease follow-up. It also allows the classification of tumors into subclasses assisting in disease diagnosis and prognosis, as well as in treatment selection. In this paper, we employed expression profiling for molecular analysis of TCC. A TCC-derived cDNA microarray was constructed and hybridized with 19 probes from normal urothelium and TCC tissues. Hierarchical clustering analysis identified all normal urothelium samples to be tightly clustered and separated from the TCC samples, with 29 of the genes significantly induced (t-test, P<10−5) in noninvasive TCC compared to normal urothelium. The identified genes are involved in epithelial cells' functions, tumorigenesis or apoptosis, and could become molecular tools for noninvasive TCC diagnosis. Principal components analysis of the noninvasive and invasive TCC expression profiles further revealed sets of genes that are specifically induced in different tumor subsets, thus providing molecular fingerprints that expand the information gained from classical staging and grading.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  • Bayer-Garner IB, Dilday B, Sanderson RD and Smoller BR . (2000). Am. J. Dermatopathol., 22, 119–122.

  • Bieller A, Pasche B, Frank S, Glaser B, Kunz J, Witt K and Zoll B . (2001). DNA Cell Biol., 20, 555–561.

  • Brown FM . (2000). Urol. Clin. N. Am., 27, 25–37.

  • Burchardt M, Burchardt T, Shabsigh A, De La Taille A, Benson C and Sawczuk I . (2000). Clin. Chem., 46, 595–605.

  • Choudry GA, Stewart PA, Double JA, Krul MR, Naylor B, Flannigan GM, Shah TK, Brown JE and Phillips RM . (2001). Br. J. Cancer, 85, 1137–1146.

  • Dobra K, Andang M, Syrokou A, Karamanos NK and Hjerpe A . (2000). Exp. Cell Res., 258, 12–22.

  • Donato R . (2003). Microsc. Res. Technol., 60, 540–551.

  • Dyrskjot L, Thykjaer T, Kruhoffer M, Jensen JL, Marcussen N, Hamilton-Dutoit S, Wolf H and Orntoft TF . (2003). Nat. Genet., 33, 90–96.

  • Engel LS, Taioli E, Pfeiffer R, Garcia-Closas M, Marcus PM, Lan Q, Boffetta P, Vineis P, Autrup H, Bell DA, Branch RA, Brockmoller J, Daly AK, Heckbert SR, Kalina I, Kang D, Katoh T, Lafuente A, Lin HJ, Romkes M, Taylor JA and Rothman N . (2002). Am. J. Epidemiol., 156, 95–109.

  • Feroze-Merzoug F, Berquin IM, Dey J and Chen YQ . (2002). Biotechniques, 32, 776–778.

  • Giordano TJ, Thomas DG, Kuick R, Lizyness M, Misek DE, Smith AL, Sanders D, Aljundi RT, Gauger PG, Thompson NW, Taylor JM and Hanash SM . (2003). Am. J. Pathol., 162, 521–531.

  • Giroldi LA, Shimazui T, Schalken JA, Yamasaki H and Bringuier PP . (2000). Morphologie, 84, 31–38.

  • Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, Mesirov JP, Coller H, Loh ML, Downing JR, Caligiuri MA, Bloomfield CD and Lander ES . (1999). Science, 286, 531–537.

  • Itoh H, Kataoka H, Tomita M, Hamasuna R, Nawa Y, Kitamura N and Koono M . (2000). Am. J. Physiol. Gastrointest. Liver Physiol., 278, G635–G643.

  • Jemal A, Thomas A, Murray T and Thun M . (2002). CA Cancer J. Clin., 52, 23–47.

  • Kataoka H, Itoh H, Uchino H, Hamasuna R, Kitamura N, Nabeshima K and Koono M . (2000). Cancer Lett., 148, 127–134.

  • Kausch I and Bohle A . (2002). Eur. Urol., 41, 15–29.

  • Koenig F, Jung K, Schnorr D and Loening SA . (2000). Clin. Chim. Acta, 297, 191–205.

  • Kwak MK, Wakabayashi N, Itoh K, Motohashi H, Yamamoto M and Kensler TW . (2002). J. Biol. Chem., 27, 27.

  • Levy A, Dang UC and Bookstein R . (1999). Genes Chromosomes Cancer, 24, 42–47.

  • Liu ET . (2003). Curr. Opin. Genet. Dev., 13, 97–103.

  • Liu N, Gao F, Han Z, Xu X, Underhill CB and Zhang L . (2001a). Cancer Res., 61, 5207–5214.

  • Liu Y, Zheng J, Fang W, You J, Wang J, Cui X and Wu B . (2001b). Chin. Med. J. (Engl.), 114, 35–38.

  • Macgregor PF and Squire JA . (2002). Clin. Chem., 48, 1170–1177.

  • Menard S, Tagliabue E and Colnaghi MI . (1998). Breast Cancer Res. Treat., 52, 137–145.

  • Mohr S, Leikauf GD, Keith G and Rihn BH . (2002). J. Clin. Oncol., 20, 3165–3175.

  • Mota F, Kanan JH, Rayment N, Mould T, Singer A and Chain BM . (1997). Am. J. Pathol., 150, 1223–1229.

  • Rotem D, Cassel A, Lindenfeld N, Mecz Y, Sova Y, Resnick M and Stein A . (2000). Eur. Urol., 37, 601–604.

  • Schamhart DH, de Boer EC, de Reijke TM and Kurth K . (2000). Eur. Urol., 37, 16–23.

  • Simms MS, Murray A, Denton G, Scholfield DP, Price MR, Perkins AC and Bishop MC . (2001). Urol. Res., 29, 13–19.

  • Simon R, Struckmann K, Schraml P, Wagner U, Forster T, Moch H, Fijan A, Bruderer J, Wilber K, Mihatsch MJ, Gasser T and Sauter G . (2002). Oncogene, 21, 2476–2483.

  • Southgate J, Harnden P and Trejdosiewicz LK . (1999). Histol. Histopathol., 14, 657–664.

  • Thykjaer T, Workman C, Kruhoffer M, Demtroder K, Wolf H, Andersen LD, Frederiksen CM, Knudsen S and Orntoft TF . (2001). Cancer Res., 61, 2492–2499.

  • Turner KJ, Crew JP, Wykoff CC, Watson PH, Poulsom R, Pastorek J, Ratcliffe PJ, Cranston D and Harris AL . (2002). Br. J. Cancer, 86, 1276–1282.

  • Van't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M, Peterse HL, van der Kooy K, Marton MJ, Witteveen AT, Schreiber GJ, Kerkhoven RM, Roberts C, Linsley PS, Bernards R and Friend SH . (2002). Nature, 415, 530–536.

  • Vila MR, Nicolas A, de Morote JI and Meseguer A . (2000). Cancer, 89, 152–164.

  • Weiner HL, Huang H, Zagzag D, Boyce H, Lichtenbaum R and Ziff EB . (2000). Neurosurgery, 47, 1400–1409.

  • Yamamoto S, Yonezawa S, Ichinose M, Miki K, Masui T, Fukushima S, Inoue H and Tatematsu M . (1996). Virchows Arch., 427, 589–594.

  • Yue H, Eastman PS, Wang BB, Minor J, Doctolero MH, Nuttall RL, Stack R, Becker JW, Montgomery JR, Vainer M and Johnston R . (2001). Nucleic Acids Res., 29, E41–E51.

Download references

Acknowledgements

We are grateful to Dr Paz Einat for helpful discussions, Dr Hagar Kalinsky and Dr Tania Fucs for their contribution to the bioinformatic analysis, Ms Ofra Oron for her excellent technical assistance and Ms Carol Borowitz for her kind help in preparing the paper.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Orna Mor.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mor, O., Nativ, O., Stein, A. et al. Molecular analysis of transitional cell carcinoma using cDNA microarray. Oncogene 22, 7702–7710 (2003). https://doi.org/10.1038/sj.onc.1207039

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1207039

Keywords

This article is cited by

Search

Quick links